RS
Russell Skibsted
Chief Financial Officer

Russell Skibsted insider trades: Processa Pharmaceuticals (PCSA) stock purchases

Chief Financial Officer, Processa Pharmaceuticals Last trade Jun 30, 2026 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$30K
Bought, last 12 months
5 buys
9
Open-market trades
since 2011
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Russell reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 30, 2026PCSA↑ Buy$6K
Jun 15, 2026PCSA↑ Buy$6K
May 15, 2026PCSA↑ Buy$6K
Apr 15, 2026PCSA↑ Buy$6K
Mar 31, 2026PCSA↑ Buy$6K
Aug 23, 2017BTX↑ Buy$5K
May 23, 2012AOLS↑ Buy$2K
May 18, 2011AOLS↑ Buy$4K
May 18, 2011AOLS↑ Buy$4K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PCSA insiders

Open-market trades in the last 12 months

About Russell Skibsted's insider trades

Russell Skibsted is Chief Financial Officer at Processa Pharmaceuticals (PCSA). Since May 18, 2011, Russell has reported 9 open-market purchases worth $45K and no sales on SEC Form 4. In the last 12 months: 5 buys ($30K).

Their filings also include grants and awards (14 filings), option exercises (2 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.